Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Bliss GVS Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1985 on BSE, Jul 2010 on NSE
Last close ₹680.90up ₹32.40 (5.00%)BSE ₹682.50
Share price at the NSE close on 29 Oct 2026. Previous close ₹648.50.
29 Oct: open ₹667.95, high ₹680.90, low ₹652.75
52-week range of traded prices to 29 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,240 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.92
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.61
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.22%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,47,694
Bliss GVS Pharma dividends
23 filed, newest first.
Feb 2026
May 2025
May 2024
May 2023
11 May · Dividend
Apr 2022
30 Apr · Dividend
May 2021
11 May · Dividend
Jun 2020
May 2019
May 2018
May 2017
May 2016
May 2015
Feb 2015
12 Feb · Dividend
Board of directors of the Company at its meeting held on February 12, 2015, has considered and approved interim dividend @ 20% ie Re. 0.20 per share of face value of Re. 1 each.
Jun 2014
2 Jun · Dividend
Board of Directors of the Company at its meeting held on May 26, 2014, has recommended a Final Dividend of 50% i.e. Rs. 0.50/- per Equity Share for the year ended March 31, 2014
May 2013
29 May · Dividend
Board of Directors of the Company at its meeting held on May 28, 2013 has recommended a dividend of 40% i.e. 0.40 per Equity Share for the year ended March 31, 2013.
Feb 2013
14 Feb · Dividend
Board of Directors of the Company at its meeting held on February 13, 2013, inter alia, has declared an Interim Dividend of 30% i.e. Re. 0.30 per equity share for the year 2012-2013.
Jun 2012
1 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2012 has recommended 40% Dividend i.e Rs.0.40 per equity share for the year ended March 31, 2012.
Nov 2011
14 Nov · Dividend
Board of Directors of the Company at its meeting held on November 11, 2011, inter alia, has declared 35% (Re. 0.35) Interim Dividend per share for the year 2011-12.
Jun 2011
1 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2011 has recommended a dividend of 30% i.e. Rs.0.30 per equity share for the year ended March 31, 2011.
Nov 2010
11 Nov · Dividend
Board of Directors of the Company at its meeting held on November 11, 2010 have recommended an Interim Dividend of 30% i.e. Rs.0.30 per Equity Share for the year 2010-2011.